J&J's Remicade approved for new pediatric use - BusinessWeek

Health Newstrack J&J's Remicade approved for brand-new pediatric use BusinessWeek Remicade is already approved As a treatment for adults with the disease. Remicade is already FDA-approved to treat 15 other conditions including rheumatoid arthritis, speckle psoriasis and Crohn's disease. REMICADE® Receives FDA approving as First Biologic attention for Pediatric ... MarketWatch (press release) FDA Okays Infliximab for Pediatric Ulcerative Colitis Medscape Johnson & Johnson Wins U.S. approving for Expanded Remicade utilization Bloomberg Sacramento Bee  - Family Practice News Digital Network  - ThirdAge each 51 news articles » Link To Article